Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Emotion Regulation in Insecure Adolescents
NCT02301715Phase 1Completed
- Sponsor
- CHU de Besançon
- Start
- Apr 2014
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in attachment disorder, sponsored by CHU de Besançon. Primary endpoint: Global Psychotherapy Assessment Classification System at 3 years. Started Apr 2014; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
attachment disorder
Beyond the preview
Go deeper on NCT02301715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301715.